MERIDIAN BEGINS DISTRIBUTION OF RAPID TEST FOR STOMACH ULCERS.
Helicobacter pylori infection is a global problem affecting approximately three billion people. Although most commonly implicated as the primary cause of stomach ulcers, H.pylori is now recognized as a direct cause of adenocarcinoma of the stomach.
Antonio Interno, senior vice president, managing director Meridian Bioscience Europe, stated, "We are excited about the potential of this new rapid test. The early acceptance of the ImmunoCard STAT HpSA test from our customers and distribution partners has been very positive. This new test is the perfect complement to our Premier Platinum HpSA test and enables us to provide important new diagnostic capabilities to any size laboratory with these patented technologies."
Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. All Meridian products are used outside of the human body and require little or no special equipment. The company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals. The company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers and physician offices in more than 60 countries around the world. The company's shares are traded through Nasdaq's National Market, symbol VIVO.
For more information, visit www.meridianbioscience.com or call 513/271-3700.
|Printer friendly Cite/link Email Feedback|
|Comment:||MERIDIAN BEGINS DISTRIBUTION OF RAPID TEST FOR STOMACH ULCERS.|
|Date:||Sep 1, 2002|
|Previous Article:||GENEFORMATICS/DE NOVO FORM DRUG DISCOVERY COLLABORATION.|
|Next Article:||FDA GRANTS "APPROVABLE" STATUS FOR TEVA'S ANDA FOR GABAPENTIN.|